Kevin Leggat is the Senior Vice President of Finance at Iambic Therapeutics, bringing extensive experience from his eight-year tenure at Recursion. He has a proven track record in scaling finance operations for biotech companies and holds a Bachelor of Arts from the University of Utahs David Eccles School of Business.
He played a pivotal role in leading Recursion through its ~$500M IPO and was instrumental in raising over $1.5 billion in capital for the company.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.